|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/18 |
| (11) | Number of the document | 2802355 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13703151.4 |
| Date of filing the European patent application | 2013-01-07 | |
| (97) | Date of publication of the European application | 2014-11-19 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2013/050131 |
| Date | 2013-01-07 |
| (87) | Number | WO 2013/105013 |
| Date | 2013-07-18 |
| (30) | Number | Date | Country code |
| 201261584675 P | 2012-01-09 | US |
| (72) |
LAURENT, Olivier Alexandre, US
LEE, Alice, US
PRESTON, Richard Ryan, US
TUMELTY, David, US
YU, Wei Hong, US
BHAT, Abhijit Suresh, US
TEMPCZYK-RUSSELL, Anna, US
|
| (73) |
Pfizer Healthcare Ireland,
9 Riverwalk National Digital Park Citywest Business Campus, Dublin 24,
IE
|
| (54) | MUTANT ANTIBODIES AND CONJUGATION THEREOF |
| MUTANT ANTIBODIES AND CONJUGATION THEREOF |